Advanced Intake™ demonstrates efficiency gains of up to 65% in adverse event recording and 90% accuracy and quality of data extraction
ArisGlobal , an innovative life sciences technology company and developer of LifeSphere®, announced details of its Advanced Intake solution , based on LifeSphere NavaX, the next-generation advanced cognitive computing engine of the company. Advanced Intake automates safety data collection and downstream workflows.
With increasing amounts of data from multiple sources, Advanced Intake leverages the latest intelligent automation technologies, including generative AI and Large Language Models (LLMs), to revolutionize adverse event (AE) intake.
Initial pilot projects have shown that Advanced Intake enables efficiency gains of up to 65% and data extraction accuracy and quality of 90% .
Advanced Intake features dynamic data extraction, i.e. H. the system can process forms intelligently and regardless of number, variation or formatting inconsistencies. Dynamic data extraction does not require any configuration of forms. Advanced Intake revolutionizes the traditional manual case processing process that was previously required to account for variability, making the entire adverse event data processing process more efficient.
Companies that use Advanced Intake benefit from additional benefits such as:
- Access to breakthrough innovation: Companies looking to leverage automation, generative AI and Large Language Models (LLMs) in relevant business contexts now have access to Advanced Intake to achieve tangible results.
- System-independent integration: Advanced Intake can be built onto existing security databases via an open architecture and seamless integrations with third-party security systems. Even if companies don’t use LifeSphere MultiVigilance , they can benefit from Advanced Intake.
- Accelerated deployment in 6-8 months: Deliver value faster with a rapid deployment process and availability of pre-validated, production-ready automation solutions.
Ann-Marie Orange , CIO and Global Head of R&D at ArisGlobal, on the importance of Advanced Intake for the industry: “ The life sciences industry is urgently looking for practical applications and technological know-how around generative AI, and ArisGlobal is ideally suited to meet these demands fulfill. Advanced Intake is an example of an innovation that helps us meet these needs. “It enables organizations to both manage growing case volumes and meet the challenge of finding seamless, easy-to-implement technologies that are proven to deliver value.”
“Pharmaceutical companies in particular are demanding more modern and efficient methods for recording case numbers and safety data. Our ArisGlobal team is not only excited about the launch of Advanced Intake, but also that we can roll it out to our customers within weeks. We have long been working with our customers to be pioneers in the field of intelligent pharmacovigilance. This product launch is another milestone toward a comprehensive suite of intelligent, integrated features as part of the LifeSphere ecosystem.”
ArisGlobal, which recently announced a series of product innovations at its Breakthrough2024 conference in London , United Kingdom , is the first life sciences R&D technology company to introduce targeted solutions to effectively leverage generative AI in the industry. Meanwhile, the company continues to host the industry-leading GenAI Council , bringing together senior pharmaceutical, academic and AI thought leaders to advance the adoption of next-generation technologies in life sciences.
Source: PRNewsWire
